Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Calcium sensing receptor stimulates breast cancer cell migration via the Gβγ-AKT-mTORC2 signaling pathway
Lennis Beatriz Orduña-Castillo1, Jorge Eduardo Del-Río-Robles1, Irving García-Jiménez1
1Department of Cell Biology, CINVESTAV, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, CP 07360, Mexico City, Mexico.
Abstract:
Calcium sensing receptor, a pleiotropic G protein coupled receptor, activates secretory pathways in cancer cells and putatively exacerbates their metastatic behavior. Here, we show that various CaSR mutants, identified in breast cancer patients, differ in their ability to stimulate Rac, a small Rho GTPase linked to cytoskeletal reorganization and cell protrusion, but are similarly active on the mitogenic ERK pathway. To investigate how CaSR activates Rac and drives cell migration, we used invasive MDA-MB-231 breast cancer cells. We revealed, by pharmacological and knockdown strategies, that CaSR activates Rac and cell migration via the Gβγ-PI3K-mTORC2 pathway. These findings further support current efforts to validate CaSR as a relevant therapeutic target in metastatic cancer.
Insights
The calcium-sensing receptor (CaSR) in breast cancer cells activates Rac, a protein crucial for cell migration. This occurs through the Gβγ-PI3K-mTORC2 pathway, suggesting CaSR as a therapeutic target for metastatic cancer.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- The calcium-sensing receptor (CaSR) is a G protein-coupled receptor implicated in cancer cell signaling.
- CaSR activation may promote cancer metastasis by influencing cellular pathways.
Purpose of the Study:
- To investigate the role of CaSR mutants in breast cancer.
- To elucidate the molecular mechanisms by which CaSR activates Rac and promotes cell migration.
Main Methods:
- Utilized various CaSR mutants found in breast cancer patients.
- Employed pharmacological inhibitors and knockdown strategies in MDA-MB-231 breast cancer cells.
- Assessed Rac activation, ERK pathway activity, and cell migration.
Main Results:
- CaSR mutants showed differential effects on Rac activation but similar activity on the ERK pathway.
- CaSR-mediated Rac activation and cell migration were dependent on the Gβγ-PI3K-mTORC2 pathway.
- Identified a novel signaling axis linking CaSR to cytoskeletal dynamics and cell motility.
Conclusions:
- CaSR signaling, particularly through the Gβγ-PI3K-mTORC2 pathway, drives Rac activation and cell migration in invasive breast cancer.
- These findings highlight the potential of targeting CaSR for the treatment of metastatic breast cancer.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
PI3K/mTOR/AKT Signaling Pathway
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Cancer Cell Migration through Invadopodia
Mitogens and the Cell Cycle